Acute coronary syndromes represent the most severe consequences of atherosclerosis, most often triggered by the rupture of a coronary plaque, which, for various reasons, has become unstable. In many cases, these rupture-prone vulnerable plaques are difficult to diagnose, because they do not always cause significant obstruction noticeable by coronary angiography. Therefore, new methods and tools for the identification of vulnerable plaques have been proposed, many of which are currently under study. Various biomarkers have been suggested as predictors of a vulnerable plaque, as well as indicators of an increased inflammatory status associated with higher patient susceptibility for plaque rupture. Integration of such biomarkers into multiple biomarker platforms has been suggested to identify superior diagnostic algorithms for the early detection of the high-risk condition associated with an unstable plaque. The aim of this review is to summarize recent research related to biomarkers used for the early detection of vulnerable plaques and vulnerable patients.
1
Acute myocardial infarction is a disease with a strong effect on patients' health and quality of life. If not treated promptly by appropriate reperfusion therapy, severe complications, such as heart failure, arrhythmia, thromboembolism or even death, may occur. Myocardial infarction (MI) can have a substantial negative impact on the social, economic and psychological status of the patients, who prior to the MI were active.
2 If the patient is treated in time, and a coronary stent is implanted at the site of the infarction, there is a lower risk of complications. However, limitations in exercise capacity, with consequent deterioration of the quality of life will remain. Therefore, effective preventive strategies aimed at moderating the progression of the "vulnerable patients" towards developing an acute myocardial infarction could lead not only to a significant reducing in healthcare costs, but also to a substantial improvement in the quality of life in these patients. 3 Acute coronary syndromes (ACS) represent the most severe consequences of atherosclerosis, most often being triggered by the rupture of a coronary plaque, which, for different reasons, becomes unstable. Plaque rupture has been identified as the pathophysiologic substrate in more than 75% of all fatal heart attacks. 4 However, it has been proved that 25-40% of STEMI are produced by plaques with an intact fibrous cap. These types of plaques usually present with lower degrees of lipid reach core, and less frequently have a thin-capped fibroatheroma. 5 One major question is why a coronary plaque suddenly becomes unstable and ruptures. Timely identification of ruptureprone plaques could lead to the appropriate initiation of suitable therapeutic measures. The ability to detect the risk of having a myocardial infarction, and to contribute to the proper treatment of these lesions before plaque rupture and consequent myocardial infarction, would assist in preventing plaque rupture and the subsequent acute coronary event. 6 In many cases, vulnerable plaques are difficult to diagnose, because they do not always cause significant obstruction as seen by coronary angiography. 4 Standard diagnostic tools, such as conventional coronary angiography, focus more on luminal narrowing than on plaque characteristics and are unable to estimate the vulnerability of a coronary plaque, and therefore cannot predict if a plaque is prone to rupture with the subsequent risk of an acute coronary event.
4
Various biomarkers have been proposed to characterize vulnerable plaques and to gauge the increased inflammatory status associated with patient vulnerability.
Integration of such biomarkers into multiple biomarker platforms has been suggested with the aim of achieving superior diagnostic algorithms for the early detection of the high-risk conditions. In this review, the most recent progress relating to the use of biomarkers for the early detection of vulnerable plaques and vulnerable patient, is summarized. 
VuLNERABLE PLAquE AND VuLNERABLE PATIENT

LOCALLY RELEASED BIOmARkERS AT THE SITE Of THE VuLNERABLE PLAquE
Impaired function of the coronary endothelium leads to local release into the coronary circulation of inflammatory or pro-thrombotic biomarkers. 16 
ImAgINg-DERIVED BIOmARkERS CHARACTERIzINg VuLNERABLE PLAquE
33
In this study, investigating twenty-one coronary arteries from seven donor hearts and correlating the histological features with CCTA appearances, the presence of the napkin-ring sign was a strong predictor for advanced coronary lesions. The study emphasized the ability of CCTA to recognize advanced atherosclerotic lesions associated with high vulnerability and increased probability for adverse cardiovascular events.
32
In a previous study, it was shown that unstable plaques are characterized by larger volumes of low-density lipid cores, and a critical volume of 0.2 ml very low CT density plaque (<30 HU) was associated with the development of an acute coronary syndrome by Benedek et al.
34
New CT-based imaging biomarkers, such as epicardial fat thickness, have been proposed as markers of coronary artery disease and the severity of plaque instability. A recent publication described the role of EFT in characterizing the severity of coronary artery disease. 24 However, the role of this EFT as a biomarker describing patient vulnerability and expressing an increased inflammatory status in patients with vulnerable plaques is yet to be clarified. At In an OCT substudy of the TOTAL trial (ThrOmbecTomy versus PCI Alone), the lipid content was lower in culprit plaques with intact fibrous plaques as compared to ruptured plaques. However, a significant lipid core was present in all the culprit plaques, while the thickness of the fibrous cap was significantly lower in ruptured plaques as compared to intact cap plaques (62.05 ± 9.13 microM vs.
91.03 ± 16.97 microM, p <0.0001). OCT -optical coherence tomography; NIRS -near infrared spectroscopy IVUS studies identified the presence of a large necrotic core as a marker of vulnerability. 37 A previous study described the association between a necrotic core determined by VH-IVUS and the low-density core within the unstable coronary plaque, demonstrating that the dark spots associated with the napkin-ring sign shown by CT, represent in fact the necrotic core of the vulnerable plaque. 
45
The noninvasive measurement of FFR combines anatomical assessment of lesion severity provided by CT with the hemodynamic assessment of functional significance, provided by computer modeling. 46 In a study which com- Nanoparticle-based imaging of vulnerable plaque:
when a plaque ruptures, the fibrous cap is injured, and the lipid core, which is thrombogenic, is exposed to circulation, inducing thrombus formation. 50 
